O9.7. TECHNOLOGY ASSISTED RELAPSE PREVENTION PROGRAM REDUCES HOSPITALIZATION IN SCHIZOPHRENIA PATIENTS AT HIGH RISK FOR RELAPSE

ITAREPS: information technology aided relapse prevention programme in schizophrenia.

ITAREPS presents a mobile phone-based telemedicine solution for weekly remote patient monitoring and disease management in schizophrenia and psychotic disorders in general. The programme provides health professionals with home telemonitoring via a PC-to-phone SMS platform that identifies prodromal symptoms of relapse, to enable early intervention and prevent unnecessary hospitalizations. Its we...

Antipsychotic drugs for relapse prevention in schizophrenia.

www.thelancet.com Vol 380 September 22, 2012 1055 trial requires it to be viewed in the context of the totality of evidence; the estimates of eff ect seen in IST-3 were comparable with, and reinforced the results of, previous trials. Fatovich and colleagues state that we had decided “ordinal analysis was not appropriate”; this was the view of the steering committee in 2009. However, as stated i...

Prodromal symptoms and relapse prevention in schizophrenia.

The value of monitoring for prodromal symptoms in patients with schizophrenia has been questioned by some investigators who point out that their positive predictive value, sensitivity, and specificity can be low in relation to relapse. This article focuses on methodological and conceptual issues which should be considered in evaluating the usefulness of prodromal symptoms and behaviors as part ...

Relapse Prevention 1 RUNNING HEAD: Relapse Prevention

Relapse Prevention

Relapse prevention (RP) is an important component of alcoholism treatment. The RP model proposed by Marlatt and Gordon suggests that both immediate determinants (e.g., high-risk situations, coping skills, outcome expectancies, and the abstinence violation effect) and covert antecedents (e.g., lifestyle factors and urges and cravings) can contribute to relapse. The RP model also incorporates num...